Unlocking the Potential of Digital Twins in Healthcare

By Staff Writer

March 28, 2024

Introduction:

The evolution of digital twins (DT) in healthcare is a testament to the innovative advancements made in the industry. Virtual model simulation of complex dynamical systems is a cost-effective technique to explore the effects of design choices and options. DT are virtual replicas of items, aiding in decision-making by representing their development and advancement. Before investing in real prototypes and assets, industrial manufacturers employ DT to simulate, anticipate, and optimise the product and production system.

Origin and Evolution of Digital Twins

DT, originally adopted by the National Aeronautics and Space Administration (NASA) in the 1960s, have found a significant place in healthcare, offering a virtual representation of a physical system. The DT concept has evolved from being a mere replica to a sophisticated representation that mirrors real-world systems in real time, providing predictive insights to aid decision making using advanced simulation.

The Rising Trend of Digital Twins in Healthcare

The surge in publications on DT in recent years is a clear indicator of the growing interest in this field. Researchers worldwide are recognising the potential of DT to transform healthcare delivery, patient care, and medical research. The application of DT in healthcare is primarily driven by technologies such as Machine Learning (ML) and Artificial Intelligence (AI). These technologies are used for modelling, simulations, and creating virtual representations, primarily focusing on patient care and advancing personalised treatments.

Different Types and Applications of Digital Twins in Healthcare

DT in healthcare can be conceived in various forms, including DTs of one body system, organ, or even at the cellular level. They can also be created for specific diseases or disorders. A composite DT integrates two or more types, providing a comprehensive view. The fidelity of a DT largely depends on the incorporation of real-time and real-world information, enhancing its utility and accuracy.

In terms of applications, Digital Twins in healthcare (DT4H) can be categorised into eight main areas. These include hospital management design and care coordination, medical device design, biomarker and drug discovery, and personalised medicine, among others. Each category utilises the power of DTs in unique ways, offering innovative solutions to existing challenges in healthcare.

Figure 1. Main applications of digital twins for healthcare

 

Digital Twins in Medical Device Design

DT are reforming the field of medical device design. One notable example is the collaboration between Dassault Systèmes and the US Food and Drug Administration (FDA) on the SIMULIA Living Heart project. This initiative aimed to create a validated DT of the human heart, providing invaluable insights into organ-drug interactions. With the power of AI and partnerships with leading healthcare companies, DT are enabling the development and refinement of cardiac devices at an unprecedented pace. The application of DT in medical device design not only accelerates the design process but also enhances the precision and effectiveness of these devices.

Challenges in Implementing Digital Twins in Healthcare

Despite the potential of DT, their implementation in healthcare comes with several challenges. Acquiring and integrating data presents a significant challenge. We also need to address issues of data privacy and security. Ensuring data quality and accuracy is another critical concern. We must tackle data bias and fairness, and consider ethical implications. The complexity of modelling also poses a challenge. Furthermore, we should focus on developing a robust computing infrastructure and compelling business models. Ensuring data accuracy, preventing biases in models, and safeguarding sensitive health information are vital to the successful implementation of DT in healthcare. Moreover, the development of appropriate computing infrastructure and business models can facilitate the broader adoption of DT in the health industry.

Conclusion:

The application of DT in healthcare is a testament to the potential of technology to reshape healthcare delivery and patient care. Despite the challenges, the transformative potential of DT in healthcare is undeniable. As technology advances and we resolve existing challenges, the importance of DT in personalised and precision healthcare will grow. By integrating real-time and real-world information into DT, we can greatly improve their fidelity. This improvement will contribute to better healthcare outcomes overall. As innovation and advancement in this field continue, DT will certainly shape the future of healthcare.

Reference url

Recent Posts

oral cancer East Africa
   

Oral Cancer in East Africa: The Need for Early Detection

💡 Did you know that Toombak use is a leading risk factor for oral cancer in East Africa?

A recent scoping review sheds light on the shocking prevalence of oral cancer in the region, emphasising the urgent need for public health interventions and improved early detection strategies. Enhancing awareness around risk factors like Toombak, tobacco, and alcohol for tackling this growing health crisis.

Curious about the key insights and their implications for health economics? Look into the full article to find out more!

#SyenzaNews #HealthEconomics #Oncology #GlobalHealth

Novartis patent cliff layoffs
     

Engineering Resilience: Mastering Pharma Patent Expiration Strategy

🚨 Are you still reacting to pharmaceutical patent expirations with layoffs and litigation, or are you ready to engineer a strategy that turns the patent cliff into your next competitive edge?

Patent expirations don’t have to derail your pharma portfolio. Learn how to outmaneuver generics and transform challenges into advantages. Dive into our latest insights and take control today.

#SyenzaNews #pharmaceuticals #innovation #PharmaStrategy #patentcliffs

diabetes medicine access
               

Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefits Scheme

🚀 Are we on the verge of a breakthrough in diabetes medication accessibility?

The latest updates to the Pharmaceutical Benefits Scheme (PBS) are set to transform type 2 diabetes management by expanding access to essential medicines like empagliflozin and streamlining the prescribing process for glucagon-like peptide 1 receptor agonists (GLP-1 RAs). These changes not only prioritize equity for high-risk populations but also align with global trends in cost-effective healthcare.

Dive deeper into how these revisions could reshape diabetes care and promote better health outcomes for all.

#SyenzaNews #HealthcareInnovation #healthcare #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.